Enterobiome Inc.
PrivateLast Round
VC Round
Sep 27, 2024
Est. Valuation
$46.67M
Total Funding Raised
$14.5M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Enterobiome Inc. is a biotechnology company that develops microbiome-based pharmaceutical products and health-functional foods for the treatment of immune diseases, metabolic disorders, and other conditions.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Enterobiome Inc. Comparables
Compare Enterobiome Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| ImmunoBiome Inc. | 88% | |
| AtoGen Co., Ltd. | 83% | |
| Nodcure Inc. | 82% |
Enterobiome Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Sep 27, 2024 | ||||
| Series B | Jan 1, 2022 | ||||
| Series A | Jan 12, 2021 | ||||
| Seed | Jun 1, 2019 |
Key People
Founding team and executive leadership
Enterobiome Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Hanwha Investment & Securities | Series A, Series B |
| iM Investment Partners | VC Round |
| Magna Investment | Series B |
| TIPS (Tech Incubator Program for Startup) | Seed |
| Metistone Equity Partners | VC Round |
| HB Investment | VC Round, Series B |
| Lighthouse Combined Investment | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 20, 2026
Monthly visitors increased 34% MoM, reaching 3.3K.
- Mar 3, 2026
Monthly visitors increased 489% MoM, reaching 2.5K.
Enterobiome Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Enterobiome Inc.'s valuation, stock price, and market status.
Is Enterobiome Inc. a public or private company?
Enterobiome Inc. is a private company.
What is the current stock price of Enterobiome Inc.?
Enterobiome Inc. is a private company with no public stock price. No recent secondary market data is available.
How much is Enterobiome Inc. worth (valuation)?
Enterobiome Inc.'s valuation is estimated at $46.7M based on funding round data.
Can I buy Enterobiome Inc. stock?
Enterobiome Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Enterobiome Inc.'s last funding round?
Enterobiome Inc.'s most recent funding round was VC Round on January 1, 2022.
Who are the main investors in Enterobiome Inc.?
Key investors in Enterobiome Inc. include Magna Investment, Metistone Equity Partners.
Will Enterobiome Inc. IPO soon?
No public IPO plans have been announced for Enterobiome Inc..
How can I track Enterobiome Inc. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Enterobiome Inc.'s secondary market activity and sign up for updates.